title: Drug coverage for transplantation turns into political football: big business trumps patients.
authors.forename: David J
authors.initials: DJ
authors.lastname: Cohen
authors.forename: Barbara
authors.initials: B
authors.lastname: Murphy
mesh_terms: D016527:Drug Costs; D004608:Eligibility Determination / Q000331:legislation & jurisprudence; D033161:Government Regulation; D018166:Health Care Reform / Q000191:economics / Q000331:legislation & jurisprudence*; D019981:Health Care Sector / Q000331:legislation & jurisprudence; D006297:Health Services Accessibility / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D019458:Insurance Coverage / Q000191:economics / Q000331:legislation & jurisprudence*; D007349:Insurance, Health, Reimbursement; D016030:Kidney Transplantation / Q000191:economics / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D028701:Patient Rights / Q000331:legislation & jurisprudence*; D006435:Renal Dialysis; D012955:Societies, Medical; D014481:United States
chemical_list: D007166:Immunosuppressive Agents